These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 16531793)

  • 1. High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors.
    Olsen MH; Christensen MK; Hansen TW; Gustafsson F; Rasmussen S; Wachtell K; Borch-Johnsen K; Ibsen H; Jørgensen T; Hildebrandt P
    J Hypertens; 2006 Apr; 24(4):655-61. PubMed ID: 16531793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    Eur Heart J; 2007 Jun; 28(11):1374-81. PubMed ID: 17242007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    J Hypertens; 2008 Jan; 26(1):26-34. PubMed ID: 18090537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
    Olsen MH; Wachtell K; Nielsen OW; Hall C; Wergeland R; Ibsen H; Kjeldsen SE; Devereux RB; Dahlöf B; Hildebrandt PR
    J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which markers of subclinical organ damage to measure in individuals with high normal blood pressure?
    Sehestedt T; Jeppesen J; Hansen TW; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Olsen MH
    J Hypertens; 2009 Jun; 27(6):1165-71. PubMed ID: 19387364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension.
    Pietri P; Vyssoulis G; Vlachopoulos C; Zervoudaki A; Gialernios T; Aznaouridis K; Stefanadis C
    J Hypertens; 2006 Nov; 24(11):2231-8. PubMed ID: 17053545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension.
    Tsai WC; Lin CC; Chen JY; Huang YY; Lee CH; Li WT; Weng CM; Chen JH
    Blood Press; 2008; 17(4):233-8. PubMed ID: 18671144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between inflammation and arterial stiffness in patients with essential hypertension.
    Kampus P; Muda P; Kals J; Ristimäe T; Fischer K; Teesalu R; Zilmer M
    Int J Cardiol; 2006 Sep; 112(1):46-51. PubMed ID: 16297996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum high sensitivity C-reactive protein is associated with carotid intima-media thickness in type 2 diabetes.
    Kang ES; Kim HJ; Kim YM; Lee S; Cha BS; Lim SK; Kim HJ; Lee HC
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S115-20. PubMed ID: 15563960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events.
    Sehestedt T; Lyngbæk S; Eugen-Olsen J; Jeppesen J; Andersen O; Hansen TW; Linneberg A; Jørgensen T; Haugaard SB; Olsen MH
    Atherosclerosis; 2011 May; 216(1):237-43. PubMed ID: 21354571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk prediction is improved by adding markers of subclinical organ damage to SCORE.
    Sehestedt T; Jeppesen J; Hansen TW; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt P; Olsen MH
    Eur Heart J; 2010 Apr; 31(7):883-91. PubMed ID: 20034972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the metabolic syndrome on the predictive values of new risk markers in the general population.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    J Hum Hypertens; 2008 Sep; 22(9):634-40. PubMed ID: 18528412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans.
    Rhee EJ; Kim YC; Lee WY; Jung CH; Sung KC; Ryu SH; Oh KW; Kim SW
    Metabolism; 2006 Feb; 55(2):183-7. PubMed ID: 16423624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association among C-reactive protein, oxidative stress, and traditional risk factors in healthy Japanese subjects.
    Dohi Y; Takase H; Sato K; Ueda R
    Int J Cardiol; 2007 Jan; 115(1):63-6. PubMed ID: 16759717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community.
    Kullo IJ; Seward JB; Bailey KR; Bielak LF; Grossardt BR; Sheedy PF; Peyser PA; Turner ST
    Am J Hypertens; 2005 Aug; 18(8):1123-9. PubMed ID: 16109328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and age-related progression of aortic stiffness.
    Safar ME; Thomas F; Blacher J; Nzietchueng R; Bureau JM; Pannier B; Benetos A
    J Am Coll Cardiol; 2006 Jan; 47(1):72-5. PubMed ID: 16386667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of the myocardial performance index in a population with high prevalences of obesity, diabetes, and hypertension: the strong heart study.
    Mishra RK; Kizer JR; Palmieri V; Roman MJ; Galloway JM; Fabsitz RR; Lee ET; Best LG; Devereux RB
    Echocardiography; 2007 Apr; 24(4):340-7. PubMed ID: 17381641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study.
    Olsen MH; Wachtell K; Ibsen H; Lindholm LH; Dahlöf B; Devereux RB; Kjeldsen SE; Oikarinen L; Okin PM;
    J Hypertens; 2006 Apr; 24(4):775-81. PubMed ID: 16531808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adiponectin: an emerging cardiovascular risk factor. The REFERENCE Study].
    Barrios V; Gómez-Huelgas R; Rodríguez R; de Pablos-Velasco P
    Rev Esp Cardiol; 2008 Nov; 61(11):1159-67. PubMed ID: 19000491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
    Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
    J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.